ESPR

#2202
Esperion Therapeutics, Inc. - Common Stock
3.1 3 USD
-0.32%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
3.13
3.13
Year Range
0.81
4.18
Daily Change
-0.32%
Monthly Change
+63.87%
6 month change
-20.56%
Year Change
+259.77%
Previous Close
3.1 4
Open
3.1 3
Low
3.1 3
High
3.1 3
Volume
69
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

News